Schematic and photograph of COVID-19 sensor strip and the printed circuit board fabricated to produce a digital sensor output.
CREDIT: Minghan Xian, Hao Luo, Xinyi Xia, Chaker Fares, Patrick H. Carey IV, Chan-Wen Chiu, Fan Ren, Siang-Sin Shan, Yu-Te Liao, Shu-Min Hsu, Josephine F. Esquivel-Upshaw, Chin-Wei Chang, Jenshan Lin, Steven C. Ghivizzani, and Stephen J. Pearton
The COVID-19 pandemic made it clear technological innovations were urgently needed to detect, treat, and prevent the SARS-CoV-2 virus. A year and a half into this epidemic, waves of successive outbreaks and the dire need for new medical solutions — especially testing — continue to exist.
In the Journal of Vacuum Science & Technology B, researchers from the University of Florida and Taiwan’s National Chiao Tung University report a rapid and sensitive testing method for COVID-19 biomarkers.
The researchers, who previously demonstrated detection of biomarkers relevant in epidemics and emergencies, such as the Zika virus, heart attacks, and cerebral spinal fluid leaks, leveraged their expertise to develop a sensor system that provides detection within one second, which is far faster than current COVID-19 detection methods.
“This could alleviate slow COVID-19 testing turnaround time issues,” said Minghan Xian, an author and a chemical engineering doctoral candidate at the University of Florida.
Detecting the presence of the virus requires amplifying the numbers of the biomarker, such as the copies of viral ribonucleic acid in the common polymerase chain reaction technique for COVID-19 detection, or amplifying the binding signal for a target biomarker. The group’s method amplifies the binding signal for a target biomarker.
“Our biosensor strip is similar to commercially available glucose test strips in shape, with a small microfluidic channel at the tip to introduce our test fluid,” said Xian. “Within the microfluidic channel, a few electrodes are exposed to fluid. One is coated with gold, and COVID-relevant antibodies are attached to the gold surface via a chemical method.”
During measurement, sensor strips are connected to a circuit board via a connector, and a short electrical test signal gets sent between the gold electrode bonded with COVID antibody and another auxiliary electrode. This signal is then returned to the circuit board for analysis.
“Our sensor system, a circuit board, uses a transistor to amplify the electrical signal, which then gets converted into a number on the screen,” said Xian. “The magnitude of this number depends on the concentration of antigen, the viral protein, present within our test solution.”
While the system’s sensor strips clearly must be discarded after use, the test circuit board is reusable. This means the cost of testing may be greatly reduced. The versatility of this technology goes far beyond detecting COIVD-19.
“By altering the type of antibodies attached to the gold surface, we can repurpose the system to detect other diseases,” said Xian. “The system can serve as a prototype for modularized, inexpensive protein biomarker sensors for expedient real-time feedback within clinical applications, operating rooms, or home use.”
Original Article: COVID-19 Testing Method Gives Results Within One Second
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Biden is still testing positive for COVID. How long will he isolate?
The White House has said Biden will again isolate for five full days, but it hasn't said if he would only end isolation after testing negative.
- Where to find free COVID testing sites
Testing for COVID has become a common part of living in the midst of this pandemic. Going out, going to work, or just meeting friends and family now carry risks. ...
- Why Animals Aren't Getting Battered By BA.5 and Omicron Like Humans Are
A new study reveals the virus is widespread among animals, but they're better protected against Omicron than humans ...
- COVID-19 infections dropped overall in Tennessee but hospitalizations are still rising
As of Saturday, the seven-day average of cases in Tennessee was 2,689, compared to the prior week's 2,888, the department reported.
- White House Doctor Provides Update on Biden’s Covid-19 Status
Biden tested positive for Covid-19 Wednesday and continues to have an "occasional cough" nearly two weeks since he first received a positive test result.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19
Serum levels of IL-1RA changed significantly, a biomarker that has a correlation with severity and mortality during COVID-19 infections LA JOLLA, Calif., Aug. 3, 2022 Helixmith announced topline ...
- Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers
In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.
- PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights ...
- Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways
Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.
- Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today ...